Hilltelligence markHilltelligence
Bills/H.R. 9421119th Congress

To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.

House: Referred
Cosponsors
2
Introduced
2026-06-24
Last action
2026-06-24

Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the House Committee on Energy and Commerce.

  2. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

No topics tagged.

Sign in to view Hilltelligence’s potential-cosponsor analysis.